Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute-care hospital admissions

被引:18
作者
Callaghan, Russell C. [1 ,2 ]
Cunningham, James K. [3 ]
Victor, J. Charles [2 ]
Liu, Lon-Mu [4 ]
机构
[1] Ctr Addict & Mental Hlth, Toronto, ON M5S 2S1, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Univ Arizona, Dept Family & Community Med, Tucson, AZ USA
[4] Natl Taiwan Univ, Dept Econ, Publ Econ Res Ctr, Taipei 10764, Taiwan
关键词
Methamphetamine; Canada; Precursor chemical legislation; Hospitalization; ARIMA; Pseudoephedrine; Ephedrine; SUPPLY CONTROL; SUPPRESSION;
D O I
10.1016/j.drugalcdep.2009.06.024
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: In response to its domestic methamphetamine problems and an emerging international consensus that methamphetamine precursor and essential chemicals should be controlled, Canada regulated its import/export of ephedrine and pseudoephedrine (precursor chemicals) in January 2003, its domestic distribution of those chemicals in July 2003, and its import/export and manufacturing of essential chemicals (e.g., toluene) in January 2004. This study examines the regulations' impact on the problem of methamphetamine-related hospital admissions in Canada. Methods: ARIMA-based intervention time-series analysis was used to assess impacts on monthly counts of Canada's methamphetamine-related acute-care hospital admissions (04/1996 to 03/2005). Cocaine-, heroin/opioid-, and alcohol-related hospital admissions were examined as quasi-control time-series. Results: No impact was found for the January 2003 regulation. The July 2003 and January 2004 regulations were associated with 20% and 21% increases, respectively, in methamphetamine-related admissions. No impacts on the quasi-control time-series were found. Conclusions: This study indicates that Canada's regulations were not associated with reductions in methamphetamine-related hospital admissions. The January 2003 regulation's focus on imports/exports rather than domestic distribution may help explain its lack of impact. In contrast, the two other regulations had salient domestic foci - domestic precursor sales (July 2003) and domestic essential chemical manufacturing (January 2004). Both regulations, however, were associated with increases in admissions, rather than declines. Government reports indicate that a shift in methamphetamine production, from smaller-scale operators to more sophisticated crime organizations (groups better able to circumvent the regulations), occurred around the times of the regulations. Such a shift could increase supply and possibly admissions. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 36 条